/
2CUREX.ST
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
2cureX AB (publ)
Based in Copenhagen, Denmark, 2cureX AB (publ) is a European medtech firm established in 2006. The company's core offering is IndiTreat, an in-vitro diagnostic test designed to forecast how cancer patients will respond to or resist various drug treatments, thereby guiding clinicians in selecting the most effective therapy. Additionally, 2cureX is actively advancing IndiTreat through clinical programs targeting a range of cancers, including breast, colorectal, ovarian, and pancreatic types.
www.2curex.com- Employees
- 14
- IPO / List date
- Nov 24, 2017
- HQ
- SE
Held by traders on TradeandTell
No one on the platform currently holds 2CUREX.ST.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in 2CUREX.ST as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded 2CUREX.ST yet.